Dual Blockade With AFatinib and Trastuzumab as NEoadjuvant Treatment for Patients With Locally Advanced or Operable Breast Cancer Receiving Taxane-Anthracycline Containing Chemotherapy--Dafne (GBG-70)
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-14-2774
Full Text
Open PDFAbstract
Available in full text
Date
March 30, 2015
Authors
Publisher
American Association for Cancer Research (AACR)